These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
235 related articles for article (PubMed ID: 25911668)
1. Pulmonary Inflammation Impacts on CYP1A1-Mediated Respiratory Tract DNA Damage Induced by the Carcinogenic Air Pollutant Benzo[a]pyrene. Arlt VM; Krais AM; Godschalk RW; Riffo-Vasquez Y; Mrizova I; Roufosse CA; Corbin C; Shi Q; Frei E; Stiborova M; van Schooten FJ; Phillips DH; Spina D Toxicol Sci; 2015 Aug; 146(2):213-25. PubMed ID: 25911668 [TBL] [Abstract][Full Text] [Related]
2. Tissue specific induction of cytochrome P450 (CYP) 1A1 and 1B1 in rat liver and lung following in vitro (tissue slice) and in vivo exposure to benzo(a)pyrene. Harrigan JA; McGarrigle BP; Sutter TR; Olson JR Toxicol In Vitro; 2006 Jun; 20(4):426-38. PubMed ID: 16198082 [TBL] [Abstract][Full Text] [Related]
3. Cytochrome b5 and epoxide hydrolase contribute to benzo[a]pyrene-DNA adduct formation catalyzed by cytochrome P450 1A1 under low NADPH:P450 oxidoreductase conditions. Stiborová M; Moserová M; Černá V; Indra R; Dračínský M; Šulc M; Henderson CJ; Wolf CR; Schmeiser HH; Phillips DH; Frei E; Arlt VM Toxicology; 2014 Apr; 318():1-12. PubMed ID: 24530354 [TBL] [Abstract][Full Text] [Related]
4. The relationship between DNA adduct formation by benzo[a]pyrene and expression of its activation enzyme cytochrome P450 1A1 in rat. Hodek P; Koblihová J; Kizek R; Frei E; Arlt VM; Stiborová M Environ Toxicol Pharmacol; 2013 Nov; 36(3):989-96. PubMed ID: 24095716 [TBL] [Abstract][Full Text] [Related]
6. Suppressive effect of 1-nitropyrene on benzo[a]pyrene-induced CYP1A1 protein expression in HepG2 cells. Cherng SH; Hsu SL; Yang JL; Yu CT; Lee H Toxicol Lett; 2006 Mar; 161(3):236-43. PubMed ID: 16280210 [TBL] [Abstract][Full Text] [Related]
7. Carcinogenic polycyclic aromatic hydrocarbons induce CYP1A1 in human cells via a p53-dependent mechanism. Wohak LE; Krais AM; Kucab JE; Stertmann J; Øvrebø S; Seidel A; Phillips DH; Arlt VM Arch Toxicol; 2016 Feb; 90(2):291-304. PubMed ID: 25398514 [TBL] [Abstract][Full Text] [Related]
8. Exposure to endocrine disruptors 17alpha-ethinylestradiol and estradiol influences cytochrome P450 1A1-mediated genotoxicity of benzo[a]pyrene and expression of this enzyme in rats. Stiborová M; Dračínská H; Bořek-Dohalská L; Klusoňová Z; Holecová J; Martínková M; Schmeiser HH; Arlt VM Toxicology; 2018 May; 400-401():48-56. PubMed ID: 29649501 [TBL] [Abstract][Full Text] [Related]
9. Protective role of cytochrome P450 1A1 (CYP1A1) against benzo[a]pyrene-induced toxicity in mouse aorta. Uno S; Sakurai K; Nebert DW; Makishima M Toxicology; 2014 Feb; 316():34-42. PubMed ID: 24394547 [TBL] [Abstract][Full Text] [Related]
10. The impact of p53 on DNA damage and metabolic activation of the environmental carcinogen benzo[a]pyrene: effects in Trp53(+/+), Trp53(+/-) and Trp53(-/-) mice. Krais AM; Speksnijder EN; Melis JP; Indra R; Moserova M; Godschalk RW; van Schooten FJ; Seidel A; Kopka K; Schmeiser HH; Stiborova M; Phillips DH; Luijten M; Arlt VM Arch Toxicol; 2016 Apr; 90(4):839-51. PubMed ID: 25995008 [TBL] [Abstract][Full Text] [Related]
11. Oral exposure to benzo[a]pyrene in the mouse: detoxication by inducible cytochrome P450 is more important than metabolic activation. Uno S; Dalton TP; Derkenne S; Curran CP; Miller ML; Shertzer HG; Nebert DW Mol Pharmacol; 2004 May; 65(5):1225-37. PubMed ID: 15102951 [TBL] [Abstract][Full Text] [Related]
13. The impact of chemotherapeutic drugs on the CYP1A1-catalysed metabolism of the environmental carcinogen benzo[a]pyrene: Effects in human colorectal HCT116 TP53(+/+), TP53(+/-) and TP53(-/-) cells. Willis AJ; Indra R; Wohak LE; Sozeri O; Feser K; Mrizova I; Phillips DH; Stiborova M; Arlt VM Toxicology; 2018 Apr; 398-399():1-12. PubMed ID: 29471073 [TBL] [Abstract][Full Text] [Related]
14. Exposure to benzo[a]pyrene of Hepatic Cytochrome P450 Reductase Null (HRN) and P450 Reductase Conditional Null (RCN) mice: Detection of benzo[a]pyrene diol epoxide-DNA adducts by immunohistochemistry and 32P-postlabelling. Arlt VM; Poirier MC; Sykes SE; John K; Moserova M; Stiborova M; Wolf CR; Henderson CJ; Phillips DH Toxicol Lett; 2012 Sep; 213(2):160-6. PubMed ID: 22759596 [TBL] [Abstract][Full Text] [Related]
15. Influence of TCDD and natural Ah receptor agonists on benzo[a]pyrene-DNA adduct formation in the Caco-2 human colon cell line. de Waard PW; de Kok TM; Maas LM; Peijnenburg AA; Hoogenboom RL; Aarts JM; van Schooten FJ Mutagenesis; 2008 Jan; 23(1):67-73. PubMed ID: 18065724 [TBL] [Abstract][Full Text] [Related]
16. Effect of dihydromyricetin on benzo[a]pyrene activation in rats. Hodek P; Fousova P; Brabencova E; Moserova M; Pavek P; Anzenbacherova E; Brotanek J; Hudecek J; Frei E; Stiborova M Neuro Endocrinol Lett; 2014; 35 Suppl 2():158-68. PubMed ID: 25638381 [TBL] [Abstract][Full Text] [Related]
17. Inhibition of aryl hydrocarbon receptor transactivation and DNA adduct formation by CYP1 isoform-selective metabolic deactivation of benzo[a]pyrene. Endo K; Uno S; Seki T; Ariga T; Kusumi Y; Mitsumata M; Yamada S; Makishima M Toxicol Appl Pharmacol; 2008 Jul; 230(2):135-43. PubMed ID: 18372000 [TBL] [Abstract][Full Text] [Related]
18. Alteration of benzo(a)pyrene biotransformation by resveratrol in Apc Huderson AC; Rekha Devi PV; Niaz MS; Adunyah SE; Ramesh A Invest New Drugs; 2019 Apr; 37(2):238-251. PubMed ID: 29931584 [TBL] [Abstract][Full Text] [Related]
19. DNA adduct formation in precision-cut rat liver and lung slices exposed to benzo[a]pyrene. Harrigan JA; Vezina CM; McGarrigle BP; Ersing N; Box HC; Maccubbin AE; Olson JR Toxicol Sci; 2004 Feb; 77(2):307-14. PubMed ID: 14691214 [TBL] [Abstract][Full Text] [Related]
20. Resveratrol, a natural aryl hydrocarbon receptor antagonist, protects lung from DNA damage and apoptosis caused by benzo[a]pyrene. Revel A; Raanani H; Younglai E; Xu J; Rogers I; Han R; Savouret JF; Casper RF J Appl Toxicol; 2003; 23(4):255-61. PubMed ID: 12884409 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]